Masitinib is safe and effective for the treatment of canine mast cell tumors.
Auteurs
Hahn KA, Ogilvie G, Oglivie G, Rusk T, Devauchelle P, Legendre A, Powers B, Leventhal PS, Kinet JP, Palmerini F, Dubreuil P, Moussy A, Hermine O
Résumé
Activation of the KIT receptor tyrosine kinase is associated with the development of canine mast cell tumors (MCT).
Lire l‘article